Sydney's Eudaemon raises $4.5M seed for hydrogel condom
What's the deal? Eudaemon TechnologiesDealroom has a profile for this one. Try Dealroom →, a Sydney-based medtech company, has raised $4.5 million in seed funding. The backers were not disclosed.
What's the endgame? Eudaemon is developing a hydrogel condom pitched as a tissue-like alternative to latex and synthetic versions. Its material is 50% water, inherently wet, latex-free, and designed to replicate the mechanical and thermal properties of human tissue.
Where the money goes: The company plans to continue its manufacturing program and prepare for pivotal clinical trials and international regulatory clearances.
Why it stands out: At $4.5 million, the round sits above roughly 95% of all seed rounds raised in Australia, making it one of the larger early-stage deals in the market.
The signal: A sizeable seed round for a consumer medtech product points to investor appetite for hardware bets that pair a familiar market with a materials-science edge — though the path runs through clinical trials and regulators before any product ships.
Read more: finsmes.com
Image credit: Eudaemon Technologies
